[1]钱杨杨,吴中华,张静,等.黄连-大黄-肉桂复方及其组分对人肝癌SMMC-7721及HepG2细胞增殖的影响[J].中国中医药信息杂志,2020,27(4):52-58.[doi:10.3969/j.issn.1005-5304.201909365]
 QIAN Yangyang,WU Zhonghua,ZHANG Jing,et al.Effects of Coptidis Rhizoma - Rhei Radix et Rhizoma - Cinnamomi Cortex Compound and Its Component on Proliferation of Hepatoma SMMC-7721 and HepG2 Cells[J].zhongguo zhongyiyao xinxi zazhi,2020,27(4):52-58.[doi:10.3969/j.issn.1005-5304.201909365]
点击复制

黄连-大黄-肉桂复方及其组分对人肝癌SMMC-7721及HepG2细胞增殖的影响

参考文献/References:

[1] Cancer Today-IARC. Globocan 2018 (China) [EB/OL].[2019-09-08]. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf.

[2] 赵河通,翟笑枫.中药复方治疗原发性肝癌的临床研究进展[J].中医药导报,2017,23(17):107-110.

[3] 艾望,夏玉坤,王秀萍,等.原发性肝癌中医药治疗研究进展[J].辽宁中医药大学学报,2018,20(3):133-136.

[4] 潘敏求,曾普华,潘博.中医药治疗中晚期原发性肝癌的规律探析[J].中医药学刊,2003,21(10):1641-1642.

[5] 邵峰,曾普华,曾光,等.基于临床数据分析原发性肝癌的证治规律[J].湖南中医药大学学报,2019,39(1):40-44.

[6] 邵峰,曾普华,郜文辉,等.中医药治疗原发性肝癌用药规律的文献研究[J].湖南中医杂志,2018,34(11):117-119.

[7] 刘小美,潘志强,方肇勤,等.黄连-大黄-肉桂复方对肝癌细胞增殖及PTEN-PI3K/AKT/SGK1信号通路的影响[J].上海中医药大学学报,2016, 30(1):50-54.

[8] LI M, ZHANG M, ZHANG Z L, et al. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-kappaB[J]. Oncol Res, 2017,25(2):233-239.

[9] SUBRAMANIAM A, SHANMUGAM M K, ONG T H, et al. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3[J]. Br J Pharmacol,2013,170(4):807-821.

[10] NG L T, WU S J. Antiproliferative activity of cinnamomum cassia constituents and effects of pifithrin-alpha on their apoptotic signaling pathways in HepG2 cells[J]. Evid Based Complement Alternat Med,2011,2011:492148.

[11] 李冀,付殷,高彦宇.中药有效组分配伍研究新进展[J].中医药信息, 2014,31(3):162-164.

[12] 隋峰,张畅斌,杜新亮,等.寒热性中药的成分对TRPV1通道蛋白功能的影响[J].中药药理与临床,2009,25(5):18-20.

[13] 苟微,管冬元,方肇勤,等.小檗碱等7味中药有效成分药性的检测[J].时珍国医国药,2011,22(11):2717-2719.

[14] SPANGLE J M, ROBERTS T M, ZHAO J J. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer[J]. Biochim Biophys Acta Rev Cancer,2017,1868(1):123-131.

[15] DONG P, KONNO Y, WATARI H, et al. The impact of microRNA- mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer[J]. J Transl Med,2014, 12:231.

[16] HAFSI S, PEZZINO F M, CANDIDO S, et al. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance[J]. Int J Oncol,2012,40(3):639-644.

[17] LIU Y, AO X, DING W, et al. Critical role of FOXO3a in carcinogenesis[J]. Mol Cancer,2018,17(1):104.

[18] FARHAN M, WANG H, GAUR U, et al. FOXO signaling pathways as therapeutic targets in cancer[J]. Int J Biol Sci,2017,13(7):815-827.

备注/Memo

基金项目:国家自然科学基金(81503481);上海中医药大学中医基础理论学科能力提升项目(A1-Z193020110)

更新日期/Last Update:

2020-03-20